VC  Pacific Horizon Ventures

http://www.pacifichorizon.com





     Office Locations:

500 Union Street, Suite 835
Seattle, WA 98101
Phone: 206-682-1181
Fax: 206-682-8077

 

Stages:

  • Early
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Pacific Horizon Ventures is a Seattle-based, early-stage venture capital firm concentrating on commercial development of novel technologies for biopharmaceutical and biomedical products. PHV prefers validation-phase investments to be in the Northwest so that the firm can devote substantial time and energy to the company's development. Other early and mid-stage investments can be in companies across North America. The firm maintains an active interest in biotechnology, drug development, therapeutic and diagnostic medical devices, computational biology and selected healthcare.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Donald J. Elmer M.A. Managing General Partner
    William G. Robbins Business Relations Principal

     

    Portfolio companies include:


      Argos Therapeutics
        web link


      CareWise
        web link


      Diametric Medical
        web link


      Focal, Inc.
        web link


      Inhibitex
        web link


      iScience Interventional
        web link


      Koronis Pharmaceuticals
        web link


      NeoPath
        web link


      Proxim
        web link


      RTIME
        web link


      SleepMed
        web link


      Tandem Medical
        web link


      Tissue Repair Company
        web link


      TransMolecular
        web link


      ViaCyte
        web link


     

    Recent News: